Abstract
Abstract: L-Fucose is one of the key metabolites in human–gut microbiome interactions. It is continuously synthesized by humans in the form of fucosylated glycans and fucosyl-oligosaccharides and delivered into the gut throughout their lifetime. Gut microorganisms metabolize L-fucose and produce short-chain fatty acids, which are absorbed by epithelial cells and used as energy sources or signaling molecules. Recent studies have revealed that the carbon flux in L-fucose metabolism by gut microorganisms is distinct from that in other sugar metabolisms because of cofactor imbalance and low efficiencies in energy synthesis of L-fucose metabolism. The large amounts of short-chain fatty acids produced during microbial L-fucose metabolism are used by epithelial cells to recover most of the energy used up during L-fucose synthesis. In this review, we present a detailed overview of microbial L-fucose metabolism and a potential solution for disease treatment and prevention using genetically engineered probiotics that modulate fucose metabolism. Our review contributes to the understanding of human–gut microbiome interactions through L-fucose metabolism.
Original language | English (US) |
---|---|
Pages (from-to) | 3869-3875 |
Number of pages | 7 |
Journal | Applied Microbiology and Biotechnology |
Volume | 107 |
Issue number | 12 |
DOIs | |
State | Published - Jun 2023 |
Keywords
- Epithelial cells
- Gut microbiome
- L-Fucose
- Short-chain fatty acids
ASJC Scopus subject areas
- Applied Microbiology and Biotechnology
- Biotechnology